Effects of Ferric Carboxymaltose on Pica among Pregnant Women in Malawi: A Substudy to a Randomized Controlled Trial

<p dir="ltr">The dataset relates to de-identified data of 862 pregnant women from Southern Malawi, who were randomised in the REVAMP (RandomisEd trial of intraVenous iron for Anaemia in Malawian Pregnant women) trial. This primary objective of the REVAMP trial explored the effect of a single dose of a modern IV iron formulation (ferric carboxymaltose) compared to standard-of-care (oral iron) for anaemia treatment in Malawian pregnant women and their neonates up to 1-month post-partum. </p><p dir="ltr">This dataset includes information on Pica, which refers to the craving and consumption of non-food items. The REVAMP trial was utilized to determine the effects of iron therapy in the second trimester, compared to standard-of-care oral iron on pica behaviors among anemic pregnant women in Malawi.</p><p dir="ltr">This project contains two separate datasets and corresponding data dictionaries which underlie the variables used in the analysis of the PICA data. These consist of:</p><p dir="ltr">- Baseline characteristics </p><p dir="ltr">- PICA </p><p dir="ltr">To maintain the privacy and confidentiality of the research participants, access is provided to de-identified data only. Certain variables have not been included due to their risk of re-identification, as outlined in the data dictionaries. These variables are available by the corresponding author (Sant-Rayn Pasricha: pasricha.s@wehi.edu.au) upon reasonable request. </p><p><br></p>